Worldwide Intraosseous Infusion Devices Industry to 2028 - by Product Type, Technology, End-user and Region

DUBLIN, April 26, 2022 /PRNewswire/ -- The "Intraosseous Infusion Devices Market, by Product Type, by Technology, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The intraosseous route offers immediate vascular access during emergency administration of drugs such as during resuscitation. Intraosseous (IO) access is the most frequently used route for emergency care of children and critically ill infants when IV access cannot be achieved rapidly. Intraosseous infusion uses the rich vascular network of bones to transport drugs and fluids from the medullary cavity to the circulation.

The response and distribution of drugs and fluid injected by the intraosseous route appears to be very similar to intravenous injection. The procedure should be limited to emergency situations when intravenous access (including umbilical vein catheterization) cannot be established in a required length of time, usually 2-5 minutes. Moreover, sternal route for IO administration of medication has shown to improve patient outcomes as compared to humeral and tibial IO administration. Furthermore, use of IO infusion in critical settings such as for patients who are obese, hypovolemic, or have poor cardiac output, and in military settings is beneficial. In such patients, administration through the IV route becomes difficult to use.

The key players operating in the market are focusing on growth strategies such as acquisitions, which is expected to boost the growth of the global intraosseous infusion devices market over the forecast period. For instance, in May 2018, PerSys Medical, a company that provides emergency medical devices worldwide, announced the completion of acquisition of MAS Med Global for production of a new smart tourniquet called ADAM. This acquisition is a significant addition to PerSys Medical's hemorrhage control portfolio.

Key features of the study:

• This report provides in-depth analysis of the global intraosseous infusion devices market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global intraosseous infusion devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include PerSys Medical, Aero Healthcare AU Pty Ltd, Teleflex Incorporated, PAVmed Inc., BIOPSYBELL S.R.L., Becton Dickinson Company, Cook Group, SAM Medical, Argon Medical Devices, Inc., Cardinal Health, Inc., StarFish Product Engineering Inc., and Medax SRL unipersonle
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global intraosseous infusion devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global intraosseous infusion devices market

Key Topics Covered:

1. Research Objectives and Assumptions

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Product Type
• Market Snapshot, By Technology
• Market Snapshot, By End User
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Opportunity
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches / Approvals
• PEST Analysis
• PORTER's Analysis
• Merger, Collaboration and Acquisitions Scenario
• Technology Trends
• Supply Chain Analysis
• Intraosseous Infusion Procedure Volume By Indication
• Intraosseous Infusion Procedure Volume By Site of Access
• Company Share Analysis

4. Global Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply side and Demand Side Analysis
• Economic Impart

5. Global Intraosseous Infusion Devices Market, By Product Type, 2017 - 2028, (US$ Mn)

• Introduction
• Market Share Analysis, 2021 and 2028 (%)
• Y-o-Y Growth Analysis, 2018 - 2028
• Segment Trends
• FAST1 Device
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• FASTx Device
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Bone Injection Gun (BIG) Devices
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• EZ-IO Device
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• NIO Device
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Dieckmann Modified Needle
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
• Jamshidi Needle
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

6. Global Intraosseous Infusion Devices Market, By Technology, 2017 - 2028, (US$ Mn)

• Introduction
• Market Share Analysis, 2021 and 2028 (%)
• Y-o-Y Growth Analysis, 2018 - 2028
• Segment Trends
• Manual IO Needles
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Battery Powered Driver
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Impact Driven Devices
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)

7. Global Intraosseous Infusion Devices Market, By End User, 2017 - 2028, (US$ Mn)

• Introduction
• Market Share Analysis, 2021 and 2028 (%)
• Y-o-Y Growth Analysis, 2018 - 2028
• Segment Trends
• Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Clinics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Ambulatory Surgical Centers
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
• Others (Pre-hospital Emergency Care, Military Hospitals)
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

8. Global Intraosseous Infusion Devices Market, By Region, 2017 - 2028, (US$ Mn)

9. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis
• PerSys Medical
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Aero Healthcare AU Pty Ltd
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Teleflex Incorporated
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• PAVmed Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• BIOPSYBELL S.R.L.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Becton Dickinson Company
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Cook Group
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• SAM Medical
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Argon Medical Devices, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Cardinal Health, Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• StarFish Product Engineering Inc.
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Medax SRL unipersonle
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Analyst Views

10. Section

For more information about this report visit https://www.researchandmarkets.com/r/fofu6x

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets